RIL's standalone PAT at Rs 80 bn washigher than our/ Street estimate of ~Rs 77 bn, driven by strong performance in petchem business and higher other income. Petchem segment EBIT was flat QoQ vs. expected decline of 12%as volume de-growth of 4% (plant shutdown) was more than offset by margin growth..